Qureight
Dan Gooding has extensive experience in the biotechnology and pharmaceutical sectors, currently serving as a Strategic Advisor at Qureight, a start-up focused on innovative imaging solutions for respiratory diseases. Gooding also holds multiple director-level positions, including Director at TRX Biosciences Limited and Executive Director at Nuformix Plc, where notable contributions include leading the company from its inception to a public listing and transforming its focus to clinical product development for fibrotic diseases. Previous roles include Consultant at Oxilio and Mandara, Business Development Director at NanoCentral, and Territory Manager at Dassault Systèmes, emphasizing new business development and commercialization strategies. Dan Gooding earned a Doctor of Philosophy (PhD) in Chemistry from the University of Leeds.
This person is not in any teams
This person is not in any offices
Qureight
2 followers
Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer.